Warning letter
West Coast Laboratories, Inc.: warning letter of Jun 12, 2024
FDA warning letter 672954 · Division of Human and Animal Food Operations West V
Key facts
| Reference number | 672954 |
|---|---|
| Company | West Coast Laboratories, Inc. |
| Subject | CGMP/Dietary Supplement/Adulterated/Misbranded |
| Issue date | Jun 12, 2024 |
| Posted date | Jul 23, 2024 |
| Issuing office | Division of Human and Animal Food Operations West V |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.73, 111.205, 111.260, 111.70(b)(2), 111.120(e), 111.123(b)(1), 111.127(h), 111.210(h)(1), 111.260(e), 111.260(f), 111.260(k)(2), 101.36(b)(1)(i) and 12 more |
| Inspection city | Gardena |
| Inspection ZIP | 90248 |
| Inspection start date | Oct 3, 2023 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: